AGN-211377

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAGN-211377

Drug Alias NameAGN-211377

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstaglandin E2 inhibitorsThromboxane A2 synthase inhibitorsProstaglandin-H2 D-isomerase inhibitors +[4]

TargetsProstanoid FP receptorProstaglandin-H2 D-isomeraseThromboxane A2 synthase +[4]

Therapy Area/IndicationsOcular inflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAllergan Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAllergan Inc

Active IndicationsN/A

Inactive IndicationsOcular inflammation

ATC CodeN/A